Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state

International Journal of Obesity

Volumn 23, Issue 5, 1999, Pages 512-517

  Avignon, Antoine ^a   Boegner C ^a   Mariano Goulart, D ^a   Colette, C ^a   Monnier, L ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Insulin resistance; Obesity; Oral glucose tolerance test; Plasma glucose; Plasma insulin

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISTRIBUTION VOLUME; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 0032940183     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800864     Document Type: Article

References (31)

1. 1 Rabinowitz D, Zierler KL. Forearm metabolism in obesity and its response to intraarterial insulin. Characterization of insulin resistance and evidence for adaptative hyperinsulinism. J Clin Invest 1962; 12: 2173-2181.
2. 2 Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima indians. N Engl J Med 1993; 329: 1988-1991.
3. 3 Shinozaki K, Suzuki M, Ikebuchi M, Hara Y, Harano Y. Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care 1996; 19: 1-7.
4. 4 Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350-357.
5. 5 Reaven GM. Banting Lecture. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
6. 6 Manson J, Colditz G, Stampfer MJ, Willett WC, Rosner B, Monson RR, Speizer FE, Hennekens. A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med 1990; 322: 882-889.
7. 7 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
8. 8 Bergman RN, Ider YZ, Bowder CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979; 236: E667-E677.
9. 9 Bergman RN, Prager R, Volund A, Olefsky JM. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J Clin Invest 1987; 79: 790-800.
10. 10 Saad MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen YD, Sands RE, Pei D, Savage PJ, Bergman RN; for the Insulin Resistance Atherosclerosis Study. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 1994; 43: 1114-1121.
11. 11 Coates PA, Luzio SD, Brunel P, Owens DR. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes 1995; 44: 631-635.
12. 12 Anderson RL, Hammann RF, Savage PJ for the Insulin Resistance Atherosclerosis Study. Exploration of Simple Insulin Sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSIGT) tests. Am J Epidemiol 1995; 142: 724-732.
13. 13 Anderson RL, Burke GL, Rewers M, Saad MF; for the Insulin Resistance Atherosclerosis study group. Assessment of insulin sensitivity in populations via intravenous glucose tolerance test: Insulin Resistance and Atherosclerosis Study (IRAS). Diabetes 1994; 43: 27A.
14. 14 Kuczmarski R, Flegal K, Campbell S, Johnson C. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994; 272: 205-211.
15. 15 Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-965.
16. 16 DeFronzo RA. The triumvirate: β-cell, muscle, liver, a collusion responsible for NIDDM. Diabetes 1988; 37: 667-687.
17. 17 Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes 1993; 42: 1663-1672.
18. 18 Golay A, Felber JP. Evolution from obesity to diabetes. Diab Metab 1994; 20: 3-14.
19. 19 Yki-Järvinen H. Role of insulin resistance in the pathogenesis of NIDDM. Diabetologia 1995; 38: 1378-1388.
20. 20 Ward WK, Beard JC, Halter JB, Pfeifer MA, Porte D Jr. Pathophysiology of insulin secretion in non-insulin dependent diabetes mellitus. Diabetes Care 1984; 7: 491-502.
21. 21 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
22. 22 WHO Study Group on Diabetes Mellitus. Diabetes Mellitus: Report of a WHO Study Group. World Health Organization: Geneva, (WHO Tech. Rep. series no. 727) 1985.
23. 23 Coates PA, Ollerton RI, Luzio SD, Ismail IS, Owens DR. Reduced sampling protocols in estimation of insulin sensibility and glucose effectiveness using the minimal model in NIDDM. Diabetes 1995; 42: 1635-1641.
24. 24 Cobelli C, Mari A, Ferrannini E. Non-steady state: error analysis of Steele's model and developments for glucose kinetics. Am J Physiol 1987; 252: E679-E689.
25. 25 Zar JH. Biostatistical analysis (2nd edn) Prentice-Hall Inc: Englewood Cliffs, 1984.
26. 26 Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop L. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989; 321: 337-343.
27. 27 Reaven GM, Hollenbeck CB, Chen Y-DI. Relationship between glucose tolerance, insulin secretion and insulin action in non-obese individuals with varying degrees of glucose tolerance. Diabetologia 1989; 32: 52-55.
28. 28 Duncan MH, Singh BM, Wise PH, Carter G. A simple measure of insulin resistance. Lancet 1995; 346: 120-121.
29. 29 Del Prato S, Pozzilli P. FIRI: fasting or false insulin resistance index. Lancet 1996; 347: 132.
30. 30 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
31. 31 Ferrannini E, Natali A, Bell P, Cavallo-Perin P, Lalic N, Mingrone G, on behalf of the European Group for the Study of Insulin Resistance (EGIR). Insulin resistance and hypersecretion in obesity. J Clin Invest 1997; 100: 1166-1173.